These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11157447)

  • 1. Diazepam in the treatment of GHB dependence.
    Addolorato G; Caputo F; Capristo E; Gasbarrini G
    Br J Psychiatry; 2001 Feb; 178():183. PubMed ID: 11157447
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of gamma-hydroxybutyric acid withdrawal syndrome during alcohol addiction treatment: utility of diazepam administration.
    Addolorato G; Caputo F; Capristo E; Bernardi M; Stefanini GF; Gasbarrini G
    Clin Neuropharmacol; 1999; 22(1):60-2. PubMed ID: 10047936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of efficacy of benzodiazepines in treating gamma-hydroxybutyrate withdrawal.
    Mullins ME; Fitzmaurice SC
    J Emerg Med; 2001 May; 20(4):418-20. PubMed ID: 11396429
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.
    Kamal RM; van Noorden MS; Wannet W; Beurmanjer H; Dijkstra BA; Schellekens A
    CNS Drugs; 2017 Jan; 31(1):51-64. PubMed ID: 28004314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detoxification of patients with GHB dependence].
    de Weert-van Oene GH; Schellekens AF; Dijkstra BA; Kamal R; de Jong CA
    Tijdschr Psychiatr; 2013; 55(11):885-90. PubMed ID: 24242149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baclofen not comparable to diazepam for alcohol withdrawal.
    O'Connor AB; Lang VJ
    Am J Med; 2007 Jun; 120(6):e5; author reply e7. PubMed ID: 17524739
    [No Abstract]   [Full Text] [Related]  

  • 7. Gamma-hydroxybutyrate withdrawal syndrome: dangerous but not well-known.
    van Noorden MS; van Dongen LC; Zitman FG; Vergouwen TA
    Gen Hosp Psychiatry; 2009; 31(4):394-6. PubMed ID: 19555805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gamma-hydroxybutyrate withdrawal syndrome.
    Tarabar AF; Nelson LS
    Toxicol Rev; 2004; 23(1):45-9. PubMed ID: 15298492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].
    van Noorden MS; Kamal R; de Jong CA; Vergouwen AC; Zitman FG
    Ned Tijdschr Geneeskd; 2010; 154():A1286. PubMed ID: 21040601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence.
    Keating GM
    Clin Drug Investig; 2014 Jan; 34(1):63-80. PubMed ID: 24307430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypernatremia caused by treatment with GHB obtained via a doctor's prescription].
    Rood IM; Seijger CG; van Waarde JA; de Maat MM; Verhave JC; Blans MJ
    Tijdschr Psychiatr; 2017; 59(1):47-51. PubMed ID: 28098924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study with Grandaxin and diazepam in alcohol withdrawal syndrome and gerontopsychiatric diseases.
    Bánki CM
    Ther Hung; 1983; 31(3):120-5. PubMed ID: 6152821
    [No Abstract]   [Full Text] [Related]  

  • 13. Inpatient GHB withdrawal management in an inner-city hospital in Sydney, Australia: a retrospective medical record review.
    Siefried KJ; Freeman G; Roberts DM; Lindsey R; Rodgers C; Ezard N; Brett J
    Psychopharmacology (Berl); 2023 Jan; 240(1):127-135. PubMed ID: 36508055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gamma-hydroxybutyrate for treatment of alcohol withdrawal syndrome in intensive care patients. A comparison between with two symptom-oriented therapeutic concepts].
    Lenzenhuber E; Müller C; Rommelspacher H; Spies C
    Anaesthesist; 1999 Feb; 48(2):89-96. PubMed ID: 10093649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe GHB withdrawal delirium managed with dexmedetomidine.
    Tay EM; Graham RI; Day RO
    Med J Aust; 2016 Sep; 205(6):251-2. PubMed ID: 27627929
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review.
    McDonough M; Kennedy N; Glasper A; Bearn J
    Drug Alcohol Depend; 2004 Jul; 75(1):3-9. PubMed ID: 15225884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe gamma-hydroxybutyrate withdrawal: a case report and literature review.
    Craig K; Gomez HF; McManus JL; Bania TC
    J Emerg Med; 2000 Jan; 18(1):65-70. PubMed ID: 10645841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inpatient management of gamma-hydroxybutyrate withdrawal.
    Cappetta M; Murnion BP
    Australas Psychiatry; 2019 Jun; 27(3):284-287. PubMed ID: 30652947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GHB: its use and misuse.
    Harv Ment Health Lett; 2001 Mar; 17(9):7-8. PubMed ID: 11276153
    [No Abstract]   [Full Text] [Related]  

  • 20. [GHB withdrawal delirium].
    Stijnenbosch PJ; Zuketto C; Beijaert PJ; Maat A
    Ned Tijdschr Geneeskd; 2010; 154():A1086. PubMed ID: 20132572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.